Literature DB >> 18476335

Synthetic carriers for vascular delivery of protein therapeutics.

Thomas D Dziubla1, Vladimir R Muzykantov.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 18476335     DOI： 10.1080/02648725.2006.10648074

Source DB:  PubMed          Journal:  Biotechnol Genet Eng Rev        ISSN： 0264-8725


× No keyword cloud information.
  7 in total

Review 1.  Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation.

Authors:  Portonovo S Ayyaswamy; Vladimir Muzykantov; David M Eckmann; Ravi Radhakrishnan
Journal:  J Nanotechnol Eng Med       Date:  2013-07-11

2.  Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers.

Authors:  Andres J Calderon; Tridib Bhowmick; John Leferovich; Bharat Burman; Benjamin Pichette; Vladimir Muzykantov; David M Eckmann; Silvia Muro
Journal:  J Control Release       Date:  2010-11-01       Impact factor: 9.776

3.  Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles.

Authors:  Michael Chorny; Elizabeth Hood; Robert J Levy; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2010-05-18       Impact factor: 9.776

4.  Catalase-coupled gold nanoparticles: comparison between the carbodiimide and biotin-streptavidin methods.

Authors:  Hariharasudhan D Chirra; Travis Sexton; Dipti Biswal; Louis B Hersh; J Zach Hilt
Journal:  Acta Biomater       Date:  2011-01-11       Impact factor: 8.947

Review 5.  Dynamic factors controlling targeting nanocarriers to vascular endothelium.

Authors:  Vladimir R Muzykantov; Ravi Radhakrishnan; David M Eckmann
Journal:  Curr Drug Metab       Date:  2012-01       Impact factor: 3.731

Review 6.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

Review 7.  The environmental pollutant, polychlorinated biphenyls, and cardiovascular disease: a potential target for antioxidant nanotherapeutics.

Authors:  Prachi Gupta; Brendan L Thompson; Banrida Wahlang; Carolyn T Jordan; J Zach Hilt; Bernhard Hennig; Thomas Dziubla
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.